Survival analysis stops regressing outcomes: SOSM lays multi-omics data on a low-curvature manifold and separates risk out-of-fold in 184 kidney cancer cases
Survival analysis has long treated censored survival times as labels for supervised regression, which overfits in high-dimensional, low-sample settings. SOSM decouples representation learning from survival labels: a contrastive loss aligns RNA, DNA methylation and miRNA views, and a pseudotime-weighted graph Laplacian penalty pulls patient embeddings onto a low-curvature manifold, with survival labels used only for out-of-fold evaluation. On a 184-patient clear cell renal cell carcinoma multi-omics cohort under five-fold cross-validation, frozen embeddings with a penalized Cox model still separated high- and low-risk groups significantly on held-out test folds.